MedTrace Logo

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

NCT04263519 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-09-27

No results posted yet for this study

Summary

A Pilot open labeled study of Tacrolimus in Alzheimer's Disease.

Conditions

Interventions

DRUG

Tacrolimus

Oral Immunosuppressant

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-12-01
Completion
2023-01-01
FDA Drug
Yes

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04263519 on ClinicalTrials.gov